Spero Therapeutics
Abigail Schwarzhans has extensive experience in quality control, currently serving as a Quality Control Associate at Spero Therapeutics since January 2020. Prior to this role, Abigail worked as an Analyst in Quality Control at Ipsen from June 2017 to June 2019, where responsibilities included tracking material lots, drafting certificates of analysis, and performing various testing methods using HPLC and UV-Vis techniques. Abigail began a career in quality control at Norwich Pharma Services, holding multiple positions from May 2015 to September 2016, including Documentation Scientist and Laboratory Technician, and gained valuable skills through internships in laboratory documentation and wet chemistry. Abigail holds a Bachelor's Degree in Chemistry with a concentration in biochemistry from SUNY Oneonta, completed in 2017.
Spero Therapeutics
2 followers
Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for bacterial infections with a world-class team of biotechnological and biopharmaceutical experts. The company has a pipeline of novel and highly differentiated antibacterial and rare disease product candidates focused on patients' unmet needs with multi-drug resistant (MDR) bacterial infections.